AZELIS GROUP N.V./ BE0974400328 /
30/05/2024 09:37:13 | Var. +0.090 | Volume | Denaro09:37:13 | Lettera09:37:13 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
19.010EUR | +0.48% | - Fatturato: - |
19.010Quantità in denaro: - | 19.020Quantità in lettera: - | 4.65 bill.EUR | 1.15% | 25.81 |
GlobeNewswire
09:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
09:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
09:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area